Observational studyAtencion primaria2026
[Diabetic neuropathy and its relationship with quality of life in patients with type 2 diabetes].
Observational study in Atencion primaria, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [Diabetic neuropathy in patients with type 2 diabetes: the need for early diagnosis].Atencion primaria · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo determine the association between diabetic neuropathy (DN) and quality of life (QoL) in patients with type 2 diabetes mellitus (DM2).
settingFamily Medicine Unit No. 33 (UMF 33), El Rosario, Azcapotzalco, Mexico City, Mexico.
designObservational, analytical, cross-sectional.
participants365 participants aged 18 years or older with a diagnosis of DM2, ascribed to a specialized diabetes care program. MEASUREMENTS: A sociodemographic questionnaire and two standardized instruments were applied: the Michigan Neuropathy Screening Instrument (MNSI), in its questionnaire (MNSIQ) and physical examination (MNSIEF) components and the SF-12v2 questionnaire to assess QoL through its physical (PCS) and mental (MCS) components. Frequencies and percentages were analyzed. The chi-square test was used for inferential statistics.
resultsAccording to the MNSIQ, 35.6% presented signs of ND, while the MNSIEF it was detected in 99.2% of the participants. 59.5% reported good physical QoL, while 61.4% reported poor mental QoL. Although descriptive differences were notable, the statistical power was limited to demonstrate consistent associations between ND and QoL.
conclusionsThe findings suggest a discordance between patient self-perception and physical examination. ND could have a negative impact on QoL, especially on the mental component (MCS). Active screening for ND in primary care settings may enhance comprehensive care and improve perceived well-being in people with DM2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.